Sr One Capital Management, LP Design Therapeutics, Inc. Transaction History
Sr One Capital Management, LP
- $297 Million
- Q1 2024
A detailed history of Sr One Capital Management, LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Sr One Capital Management, LP holds 6,526,476 shares of DSGN stock, worth $21.6 Million. This represents 8.85% of its overall portfolio holdings.
Number of Shares
6,526,476
Previous 6,526,476
-0.0%
Holding current value
$21.6 Million
Previous $17.3 Million
52.07%
% of portfolio
8.85%
Previous 8.62%
Shares
2 transactions
Others Institutions Holding DSGN
# of Institutions
95Shares Held
30.5MCall Options Held
100Put Options Held
100-
Logos Global Management LP San Francisco, CA5.03MShares$16.7 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.27MShares$7.53 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY1.66MShares$5.5 Million0.08% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$4.9 Million0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.29MShares$4.26 Million0.0% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $185M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...